Sensus Healthcare, Inc.
SRTS
NASDAQ·Healthcare·Medical - Devices·Mkt cap $52.5M
$3.19
▼ -2.15%
P/E
-19.94
Mkt Cap
$52.5M
52-Wk Range
$2.66–$5.49
52-Week Range
$2.66 - $5.49
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 1.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Strong
+18.1% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SRTS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 13, 2026
Reported EPS of -$0.53 vs -$0.13 consensus (-324.0% surprise). Revenue of $2.3M vs $4.6M expected (-50.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-324.0%
Revenue trend · last 2Q
—
-69%
Q1 26
Q2 26
$3.4M
$2.3M
Margins · last 2Q
Gross
33.6%
Operating
-138.9%
Profit
-382.1%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Lake Street · Aug 14, 2026
vs Industry
How SRTS stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.